1.
Lembas A, Załęski A, Mikuła T, Jabłońska J, Barczak S, Badura B, et al. Differences in the course of hepatocellular carcinoma depending on the DAA treatment. Prosp. Pharm. Sc. [Internet]. 2024 Aug. 16 [cited 2024 Dec. 22];22(3):114-9. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/236